Anca Iuliana T.
- Country
- Romania
- Department
- Clinical Trials Center, Antibiotice S.A.
Research Overview
- Bioequivalence Study of Nitrofuranoin 100 mg Prolonged-Release Capsules in Healthy Subjects Under Fed Conditions
- Bioequivalence Study of Cefixime 400 mg Hard Capsules Versus Cefixime 400 mg Film-Coated Tablets in Healthy Subjects
- Bioequivalence Study of Naproxen 500 mg/Esomeprazole 20 mg Modified-Release Tablets Versus Vimovo® in Healthy Subjects
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Bioequivalence Studies
The investigator specializes in conducting bioequivalence studies evaluating various pharmaceutical formulations under different physiological conditions.
- Fed state assessments
- Fasting state evaluations
- Crossover replicate designs
Focuses on comparing innovative drug formulations with established reference products.
Therapeutic Areas
Demonstrates expertise in evaluating medications across multiple therapeutic categories including anti-inflammatory, gastrointestinal, and antimicrobial agents.
- NSAID combinations
- Proton pump inhibitors
- Antibiotics
- Urinary anti-infectives
Specializes in modified-release and prolonged-release formulations assessment.
Clinical Assessment
Conducts research with healthy volunteer populations to establish pharmaceutical equivalence and comparative bioavailability.
- Single-dose studies
- Comparative effectiveness
- Safety evaluations
Focuses on establishing therapeutic equivalence between generic and branded medications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.